Pfizer, US ink $5.29B deal for possible COVID-19 treatment - ABC News

Retrieved on: 2021-11-18 18:04:03

Tags for this article:

COVID-19 vaccination in the United States

Clinical trials

Pfizer-BioNTech COVID-19 vaccine

Treatment and management of COVID-19

COVID-19 vaccine

Merck Manual of Diagnosis and Therapy

Pfizer Inc.

New York

United States

Click the tags to see associated articles and topics

Pfizer, US ink $5.29B deal for possible COVID-19 treatment - ABC News. View article details on HISWAI: https://abcnews.go.com/Health/wireStory/pfizer-us-ink-529-deal-covid-19-treatment-81251383

Excerpt

The U.S. government will pay drugmaker Pfizer $5.29 billion for 10 million treatment courses of its potential COVID-19 treatment if regulators ...

Article found on: abcnews.go.com

View Original Article